Zur Rose Group via its subsidiary Zur Rose Finance successfully completed the placement of senior unsecured bonds due 2025 guaranteed by the Company and convertible into registered shares of the Company.
Tags :Roland Truffer
Bär & Karrer acted as Swiss legal advisor to Novartis in the acquisition of NASDAQ-listed biopharmaceutical company The Medicines Company for USD 9.7 billion